Issue link: http://osercommunicationsgroup.uberflip.com/i/709458
O s e r C o m m u n i ca t i o n s G r o u p B o s t o n Tu e s d a y, A u g u s t 9 , 2 0 1 6 AN INDEPENDENT PUBLICATION NOT AFFILIATED WITH NACDS MCURE Health Solutions, Inc. is exhibiting new product extensions for its foot care line, wax strips and nose pore strips in booth #1964 at the Total Store Expo. COST-EFFECTIVE QUALITY FROM MCURE PDQ Communications continues to lead the way in email programs to pharmacists and pharmacy technicians. Its best email practices can help your message be seen by more than 340,000 pharmacists and F a m i l i e s will have a new tool to actively address concerns with the responsible use of medications thanks to Mallinckrodt Pharmaceuticals' donation of 1.5 million drug Cornerstone Automation S y s t e m s (CASI) is proud to announce a significant advance- ment in pharmacy automation technology: The Next Generation A m n e a l Pharmaceuticals, with U.S. head- quarters in B r i d g e w a t e r , New Jersey, and i n t e r n a t i o n a l headquarters in Zug, Switzerland, The phar- macy indus- try is aware of the facts. Each year, prescription non- adherence in the U.S. costs more than $230 billion dollars annual- ly, contributes to 10 percent of An inter- view with Kenneth A. Harrington, Vice President of National Sales and Marketing, TAGI Pharma. CDD: What is TAGI Pharma? C o ntinued o n P age 8 5 C o ntinued o n P age 8 4 D a v i d Biernbaum is a business development and equity- building specialist for consumer brands before and after they go to market in in retail stores. The C o ntinued o n P age 8 4 C o ntinued o n P age 7 7 C o ntinued o n P age 8 4 C o ntinued o n P age 8 5 C o ntinued o n P age 8 4 C o ntinued o n P age 7 7 PDQ EXPANDS ELECTRONIC MEDIA CAPABILITIES DIVA INTL: CHANGING THE FEMININE CARE CATEGORY THE FIGHT AGAINST PRESCRIPTION DRUG ABUSE THE FUTURE OF PHARMACY AUTOMATION AMNEAL FOCUSED ON QUALITY, INTEGRITY SPECIALTY PHARMACEUTICALS FROM TAGI PHARMA SINGLE SOURCE PATIENT COMMUNICATION BRANDS POWERED BY DAVID BIERNBAUM & ASSOCIATES LLC An interview with Darren Shirley, Vice President Vendor Relations, R&S Northeast LLC. CDD: Tell our readers about PHARMACEUTICAL WHOLESALE SERVICES FROM R&S An interview with Jerry Dowell, President and Chief Executive O f f i c e r , DowellGroup. CDD: When you started the "We will be able to recoup over seven times our investment money with this prod- uct." How would you like to say those words to your organization on Monday M e d i c a t i o n adherence is a $1 billion problem, and retail phar- macies are in the best position to help fix it. Pharmacies have historically C o ntinued o n P age 7 5 C o ntinued o n P age 7 5 C o ntinued o n P age 7 7 C o ntinued o n P age 7 7 DOWELLGROUP: YOUR PARTNER IN SUCCESS A t t e n t i o n - D e f i c i t Hyperactive Disorder is a b e h a v i o r a l disorder defined by symptoms such as inattentiveness and hyperactivity. Children with An interview with Daniela Masaro, Brand M a r k e t i n g Manager, Diva International Inc. CDD: Tell our readers about C o ntinued o n P age 8 5 C o ntinued o n P age 7 5 LUPIN: SUPPORTING ADHD PATIENTS An interview with Shane Nielsen, Vice President of Global Sales and M a r k e t i n g , OraTech. CDD: Tell our readers about C o ntinued o n P age 7 5 IMPROVE PROFITABILITY WITH ORATECH EAR COME THE PROFITS CAN TECHNOLOGY BOOST MEDICATION ADHERENCE?